LTD. (HANGZHOU DAC), a global leader in ADC innovation. Per the terms of the license agreement, Aadi is granted exclusive rights to certain patents and know-how pertaining to three preclinical ADC ...

PMCC_XCM_64x64_D IP block is a low-power array of 1GHz clocked Cross-Correlator cells that are synchronously acquiring two sets of 64x2-bit data streams which are derived by digitizing IF signals at a ...

Abstract: The increased usage of wireless services in the congested electromagnetic spectrum has caused communication systems to contend with the existing operational radar frequency bands. Integrated ...

The Peoples Redemption Party (PRP) and the African Democratic Congress (ADC) have announced a potential merger aimed at addressing Nigeria’s most pressing issues, including the decline of ...

Daiichi will invest 1.1 billion Chinese yuan ($152 million) to build a new antibody-drug conjugate (ADC) manufacturing facility in Shanghai, the Japanese pharma said (Chinese), on the heels of ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the ...

This resignation was contained in a letter dated December 8, which was addressed to Chief Okey Nwosu, National Chairman of ADC. According to him, his resignation was hinged on a mismatch of ...

Suven Pharma has acquired a majority stake in NJ Bio, marking a strategic expansion into the Antibody-Drug Conjugates (ADC) sector. Vivek Sharma of Suven Pharma, emphasized that this acquisition ...

Look closely at this image, stripped of its caption, and join the moderated conversation about what you and other students see. By The Learning Network Look closely at this image, stripped of ...

As­traZeneca and Dai­ichi Sankyo have un­veiled new da­ta on their TROP2-di­rect­ed ADC in pre­treat­ed lung can­cer pa­tients with EGFR-mu­tat­ed dis­ease, adding to their case for … ...

Du­al­i­ty Bi­o­log­ics and BioN­Tech say in­ter­im da­ta on one of their part­nered AD­Cs look en­cour­ag­ing, with a pre­lim­i­nary cut from the tri­al show­ing that near­ly … ...

Duality Biologics has shared the first data from a phase 1/2a antibody-drug conjugate (ADC) trial, giving an early look at how the BioNTech-partnered asset is shaping up against rival molecules in ...